Nationwide Recall on Birth Control Pills Due to Packaging Error

Janita Kan
By Janita Kan
March 5, 2019US News
Nationwide Recall on Birth Control Pills Due to Packaging Error
Drospirenone and Ethinyl Estradiol Tablets, USP have been recalled due to a packaging error. (FDA)

A birth control product is being recalled nationwide due to a packaging error that could cause people to take incorrect doses, according to the Food and Drug Administration.

Apotex Corp. is voluntarily recalling four lots of Drospirenone and Ethinyl Estradiol Tablets, USP as they may possibly contain defective blisters with incorrect tablet arrangements or empty blister pockets.

“As a result of this packaging error, where a patient does not take a tablet due to a missing tablet or that a patient takes a placebo instead of an active tablet, loss of efficacy is possible due to variation in the dosage consumed. To date, no case has been reported for pregnancy and adverse event to Apotex,” the company said in their statement.

According to the statement, the tablets are indicated for use by women to prevent pregnancy. People who are currently using the affected products or have questions are encouraged to contact their pharmacy.

The affected Drospirenone and Ethinyl Estradiol Tablets, USP can be identified by their NDC numbers stated on the inner and outer cartons:

NTD Photo

Drospirenone and Ethinyl Estradiol tablets usually consist of 28 film-coated tablets in the following order: 21 yellow color tablets, each containing 3 mg drospirenone and 0.03 mg Ethinyl Estradiol, and 7 placebo white color tablets.

The company has included photos of some of the affected products with missing blisters and incorrect arrangements:

NTD Photo

The company also said the affected products were distributed across the country to wholesalers and distributors.

Consumers with questions regarding this recall can contact Apotex corp. by phone-number 1-800-706-5575 or email address [email protected]. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.

From The Epoch Times

ntd newsletter icon
Sign up for NTD Daily
What you need to know, summarized in one email.
Stay informed with accurate news you can trust.
By registering for the newsletter, you agree to the Privacy Policy.